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Linking Colorectal Cancer to Wnt Signaling Review
However, a link between APC and Wnt signalingMariann Bienz*‡ and Hans Clevers†‡
emerged shortly after this, when the Wnt pathway was*MRC Laboratory of Molecular Biology
discovered by genetic analysis in Drosophila. SpecificHills Road
mutant phenotypes led to the identification of criticalCambridge CB2 2QH
Wnt signaling components, while epistasis experimentsUnited Kingdom
determined the functional order of these components‡Department of Immunology and
in the pathway. This established that Armadillo, the flyCenter for Biomedical Genetics
homolog of b-catenin, mediates most if not all responsesUniversity Medical Center
to signaling during normal development by Wingless,P.O. Box 85500
the archetypal Wnt ligand in Drosophila (Perrimon,3508 GA Utrecht
1994). Vertebrate homologs of all Wingless pathwayThe Netherlands
genes were found. Injection of Wnt pathway compo-
nents into early Xenopus embryos induced secondary
body axes. Utilizing this versatile assay, it was demon-Human cancer results from the accumulation of multiple
strated that the function of Wnt signal transducers isindependent genetic alterations. Studies of inherited
highly conserved between Drosophila and vertebratesand sporadic colorectal cancer have demonstrated that
(Miller and Moon, 1996).in the overwhelming number of cases the primary muta-
Our review centers on the question of how the deregu-tion targets a single signal transduction pathway. A story
lation of b-catenin leads to malignant development inhas rapidly unfolded in which the Wnt signaling pathway
the mammalian gut epithelium. In focus will be the func-plays a central role in the etiology of this cancer. The
tion of APC, still poorly understood at the molecularsequence of discoveries provides a classic example of
level. We shall present new insights into how APC con-the synergy between insights gained from genetic stud-
trols b-catenin. We shall also summarize recent evi-ies of model organisms and cancer biology in man.
dence suggesting that the loss of APC affects processes
other than transcription, and that these may contributeIntroduction
to tumor progression. Our aim is to illustrate how manyTumors of the colorectum are amongst the most com-
of the new discoveries that are relevant to colorectalmon human neoplasms. Approximately 5% of the West-
cancer in humans have emerged from genetic and cell-ern population will develop colorectal malignancies dur-
biological studies in animal model systems.ing their lifetime. A small fraction of these occur in an
apparently inherited fashion. One of the best defined
The Canonical Wnt Pathwaythough rare forms of such cancer syndromes is familial
Combined work in flies, frogs, and mammals producedadenomatous polyposis (FAP). Patients with FAP de-
the main outline of the canonical Wnt/b-catenin signal-velop large numbers of benign adenomatous polyps of
ing pathway as we currently know it (Figure 1). Thisthe colorectal epithelium in early adulthood. Almost in-
pathway plays a key role during normal animal develop-variably, some of these will progress into invasiveness
ment (Cadigan and Nusse, 1997). In the following, weand, ultimately, metastasize. With variable penetrance,
shall attempt to sketch out the core issues regardingFAP patients will also develop neoplastic lesions at ex-
the transduction of the Wnt signal, focusing on aspectstracolonic sites, for example desmoids, ampullary carci-
that are relevant to cancer. For more comprehensivenomas, and hepatoblastomas (Kinzler and Vogelstein,
information on this pathway, the reader is referred to
1996; Lal and Gallinger, 2000).
the Wnt homepage (http://www.stanford.edu/rnusse/
In 1991, the tumor suppressor Adenomatous polypo-
wntwindow.html).
sis coli (APC) encoded by the FAP locus was identified In unstimulated cells, free cytoplasmic b-catenin/Ar-
by molecular cloning (Groden et al., 1991; Kinzler et al., madillo is destabilized by a multiprotein complex con-
1991). It turned out that, not only the tumors from FAP taining Axin (or its homolog Conductin), glycogen syn-
patients, but also most sporadic colorectal tumors have thase kinase 3b (GSK3, or Shaggy/Zeste-white 3 in
both APC alleles inactivated (Nagase and Nakamura, Drosophila) and the APC tumor suppressor (Zeng et al.,
1993). APC is a large protein whose sequence, at the 1997; Behrens et al., 1998; Hart et al., 1998; Fagotto et
time, was uninformative. Physical interactions of APC al., 1999; Kishida et al., 1999a). Axin/Conductin has a
with several cellular proteins were tentatively identified. scaffold function in this complex, binding to APC, GSK3,
The discovery that APC binds to b-catenin (Rubinfeld and b-catenin/Armadillo. Interaction between Axin and
et al., 1993; Su et al., 1993) provided the first significant GSK3 in the complex facilitates efficient phosphoryla-
clue as to the molecular function of APC, and identified tion of b-catenin by GSK3 (Ikeda et al., 1998), most likely
what is now thought to be its most critical molecular at critical serine and threonine residues in its N terminus
target. (Aberle et al., 1997). This phosphorylation event ear-
This discovery initially suggested a function of APC marks b-catenin/Armadillo for ubiquitination by the SCF
in cadherin-based cellular adhesion in which b-catenin complex (containing the F box protein bTrCP/Slimb)
plays a critical role (e.g., Hu¨lsken et al., 1994; see below). (Jiang and Struhl, 1998; Marikawa and Elinson, 1998),
and for subsequent degradation by the proteasome
pathway (Aberle et al., 1997).‡ E-mail: mb2@mrc-lmb.cam.ac.uk [M. B.], h.clevers@lab.azu.nl [H. C.]
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Figure 1. The Canonical Wnt Pathway
Activators of the pathway are white; negative
regulators are gray. Left, in the absence of
Wnt stimulation, the Axin complex actively
earmarks b-catenin/Armadillo (white circles)
for degradation by the proteasome. The lev-
els of cytoplasmic b-catenin/Armadillo are
low, and TCF is repressed. Right, after Wnt
stimulation of the Frizzled receptor (arbitrarily
drawn to be in the apical membrane), Dsh is
recruited to the membrane where it binds to
Axin to inhibit the Axin complex. b-catenin/
Armadillo accumulates and, after transloca-
tion into the nucleus, binds to TCF to co-
activate Wnt target genes. Inhibition of the
Axin complex by GBP/Frat appears to be an
alternative to Wnt-mediated inhibition. CBP
switches from being a negative regulator to
being a coactivator, apparently depending
on the stimulation status of the cell. Note also
the apicolateral adherens junctions to which
the Axin complex appears to be anchored.
These junctions are formed by the transmem-
brane protein E-cadherin (black bars) which
is linked to the actin cytoskeleton (thin lines)
by b-catenin/Armadillo and a-catenin (black
dots).
When cells are stimulated by Wnt ligands, the cyto- by virtue of an intrinsic ability that does not depend
on the Ran/importin machinery (Fagotto et al., 1998;plasmic protein Dishevelled is recruited to the mem-
brane (Axelrod et al., 1998; Boutros et al., 2000). Dishev- Yokoya et al., 1999). Once in the nucleus, b-catenin/
Armadillo binds to TCF (T cell factor) proteins and serveselled appears to inhibit the Axin complex by direct
binding to Axin (Kishida et al., 1999a; Smalley et al., as a coactivator of TCFs to stimulate transcription of
Wnt target genes (Behrens et al., 1996; Molenaar et al.,1999). Whether Dishevelled binds directly to Frizzled,
the seven transmembrane receptors for the Wnt ligands 1996). Interestingly, TCFs are context-dependent tran-
scription factors with an architectural role in enhancer(Bhanot et al., 1996), or whether intermediary proteins
are involved in the signal transmission between Frizzled complex assembly: often, TCF function depends on
partner proteins and on simultaneous signaling by otherand Dishevelled is unknown at present. Also, the mecha-
nism of Dishevelled-mediated inhibition of the Axin com- pathways (Carlsson et al., 1993; Giese and Grosschedl,
1993; Riese et al., 1997). Thus, TCF plays a key role inplex is not understood, but one suggestion has been that
Dishevelled may cause disintegration of this complex a cell’s task of integrating multiple positional inputs.
The activity of TCFs is tightly controlled. In the ab-(Kishida et al., 1999b). Alternatively, dorsal cells in the
Xenopus embryo cells seem to inactivate the Axin com- sence of Wnt signaling, TCF target gene transcription
is actively repressed by negative regulators that bind toplex in a process that does not apparently involve the
stimulation of Frizzled receptors by Wnt ligands: in these TCF. These can be corepressors of the Groucho family
(Cavallo et al., 1998; Roose et al., 1998), or the Xenopuscells, GBP/Frat can inhibit GSK3 by preventing its bind-
ing to Axin (Yost et al., 1998; Farr et al., 2000). C-Terminal Binding Protein (XCtBP) (Brannon et al.,
1999). Another negative regulator, the histone acetyl-Wnt signaling triggers the inhibition of a constitutive
cellular activity, namely the destabilization of free cyto- transferase CBP/p300, acetylates TCF and interferes
with its binding to Armadillo, and the phenotype of dCBPplasmic b-catenin by the Axin complex. How this com-
plex is inhibited rapidly and comprehensively in re- mutant embryos suggests that this activity of dCBP pri-
marily antagonizes Wnt signaling in cells that are weaklysponse to ligand-bound Frizzled remains a mystery. One
suggestion has been that the efficacy of the inhibitory stimulated (Waltzer and Bienz, 1998). In contrast, in
mammalian cells that contain high levels of activatedprocess may be achieved by anchorage of the Axin
complex at the membrane, in the vicinity of the Frizzled b-catenin, CBP behaves as a transcriptional coactivator
of TCF and b-catenin (Hecht et al., 2000; Takemaru andreceptor (Yu et al., 1999) (Figure 1). The basis for this
was the observation that Drosophila APC is associated Moon, 2000).
Clearly, the stability of free cytoplasmic b-catenin/with adhesive membrane junctions; evidence suggested
that this junctional association is essential for APC’s Armadillo is at the heart of the canonical Wnt pathway.
Two lines of genetic evidence from Drosophila demon-function in destabilizing Armadillo (Yu et al., 1999;
McCartney et al., 1999). The subcellular localization of strate that most if not all effects of Wingless signaling are
mediated by nuclear Armadillo and TCF. First, signaling-Axin in the apical submembrane compartment of embry-
onic Xenopus cells is consistent with this anchorage deficient alleles of armadillo suppress all known defects
of Wingless overactivation in the embryo (Noordermeermodel (Zeng et al., 1997; Fagotto et al., 1999).
Stabilized b-catenin/Armadillo is somehow released et al., 1994; Peifer et al., 1994; Siegfried et al., 1994; Yu
et al., 1996). Second, Drosophila dTCF mutant embryosfrom the Axin complex and translocates into the nucleus
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closely resemble armadillo and wingless mutant em- al., 1997). These mutations render b-catenin refractory
to destruction by the Axin complex (see above). Similarbryos (Brunner et al., 1997; van de Wetering et al., 1997).
b-catenin mutations were detected in a wide variety ofHowever, it is worth noting that some Wnt ligands and
other tumor types, including melanomas, gastric cancer,Frizzled receptors effect responses, including the con-
hepatocellular carcinomas, and hair follicle tumors (Ru-trol of planar polarity, that are not transduced by
binfeld et al., 1997; Polakis, 2000). Furthermore, a frac-b-catenin/Armadillo and TCF (e.g., Boutros et al., 2000).
tion of hepatocellular carcinomas with wild-type b-cat-These pathways are thus distinct from the above-
enin show Axin mutations (Satoh et al., 2000). Finally,described canonical pathway. Furthermore, as already
Conductin mutations have recently been found amongmentioned, b-catenin/Armadillo has an additional func-
DNA mismatch repair–deficient colorectal cancers withtion which is genetically and physically separable from
intact APC (Liu et al., 2000). These Axin and Conductinits function as a Wnt transducer (Figure 1): it binds to
mutations apparently only affect one allele; therefore,the homotypic adhesion molecule E-cadherin and links
their oncogenic effect may be due to a dominant-nega-the cadherin junctions to the actin cytoskeleton to medi-
tive activity of the mutant Axin/Conductin truncationsate cellular adhesion (Ben-Ze’ev and Geiger, 1998). The
which causes stabilization of free b-catenin (see Beh-two functions of b-catenin/Armadillo are executed by
rens et al., 1998; Hart et al., 1998).separate protein pools, the free cytoplasmic pool and
The evidence is now compelling that stabilized freethe membrane-bound junctional pool which are in equi-
b-catenin is an early event during, and perhaps evenlibrium with each other (Fagotto et al., 1996; Orsulic and
initiates, tumorigenesis in the mammalian intestinalPeifer, 1996; Sanson et al., 1996).
tract. First, the smallest detectable intestinal adenomasAs mentioned above, the canonical Wnt pathway is
in heterozygous ApcD716 knockout mice lack the re-highly conserved between Drosophila and vertebrates.
maining wild-type copy of the Apc gene (Oshima et al.,Indeed, some of the Wnt-transducing components func-
1995). In humans too, inactivation of both APC allelestion almost interchangeably between Drosophila and
has been found in a majority of small colorectal adeno-mammalian cells (e.g., Siegfried et al., 1992; Hayashi et
mas (Nagase and Nakamura, 1993; Kinzler and Vo-al., 1997; Hamada et al., 1999). However, the pathway
gelstein, 1996). Second, conditional knockin mutationis less conserved in the nematode C. elegans. For exam-
in mice of one of the b-catenin alleles to an oncogenicple, the nematode genome does not appear to encode
form (bearing an N-terminal deletion which removes thean Axin homolog, nor a true functional homolog of APC
GSK3 target sites) produces adenomatous polyps in thesince its only APC-related protein APR-1 (Rocheleau et
intestine and microadenomas in the colon (Harada etal., 1997) fails to bind to b-catenin/BAR-1 (Korswagen
al., 1999). Also, in the mouse skin, transgenic expressionet al., 2000). Also, C. elegans has three b-catenin-like
in the epidermis of b-catenin with a similar N-terminalgenes. One of these, HMP-2, is dedicated to cellular
deletion causes hair follicle tumors (Gat et al., 1998).adhesion, while another homolog, BAR-1, functions ex-
What are the initial effects of APC loss or stabilizedclusively in the canonical Wnt pathway to mediate TCF
b-catenin in the mammalian intestine? To address thiscoactivation (Korswagen et al., 2000). The best-studied
question, we briefly introduce the structure and cell biol-nematode b-catenin, WRM-1, signals during the polar-
ogy of the mammalian gut epithelium. Although thereization of early embryonic cells (Thorpe et al., 1997).
are morphological differences between the differentTo date, no functional homolog of WRM-1 has been
sections along the intestinal axis (e.g., between the smalldescribed in other species.
intestine and the colorectal section), the basic design
of the intestinal epithelium remains essentially the same.
Early Events during Colorectal Tumorigenesis The epithelium of the small intestine comprises alternat-
Some 85% of all sporadic and hereditary colorectal tu- ing crypts and villi (Potten and Loeffler, 1990) (Figure
mors show loss of APC function (Kinzler and Vogelstein, 2A). The crypts contain the stem cell compartment at
1996). Colon cancer cells with mutant APC contain high their bases from which proliferating cells slowly migrate
levels of free b-catenin which can be downregulated up toward the villus while differentiating into various
by exogenous wild-type APC (Munemitsu et al., 1995). distinct cell types. Thus, cell differentiation and migra-
Stabilized b-catenin effects a transcriptional response tion are intimately linked in this process. On reaching
that is thought to be critical in tumorigenesis (Korinek the villar apex, the differentiated cells eventually die and
et al., 1997). It is now commonly accepted that the key are shed into the gut lumen. This cycle of proliferation
tumor suppressor function of APC lies in its ability to and subsequent differentiation is remarkably active and
destabilize free b-catenin (Smits et al., 1999; von Kries fast: in the small intestine of the mouse, 60% of crypt
et al., 2000). Likewise, the main function of APC during cells pass through the cell cycle every 12 hr, and the
normal development of flies and frogs is to antagonize enterocytes, the principal epithelial cells, pass from the
Armadillo and b-catenin (Ahmed et al., 1998; Yu et al., base to the top of a villus in 2–3 days. More than 108
1999; McCartney et al., 1999; Farr et al., 2000). cells are shed per day in the mouse, z1011 cells in the
The tenet that stabilized b-catenin can initiate malig- human, small intestine (Potten and Loeffler, 1990). Inter-
nant development was considerably strengthened by estingly, mouse Tcf4, a TCF family member specifically
discoveries of mutations in other Wnt pathway genes expressed in the epithelia of the mammary gland and
which, like loss of APC, cause free b-catenin to accumu- the intestinal tract, is required for the maintenance of the
late. Among the 15% colon carcinomas that retain wild- undifferentiated cycling crypt cell compartment (Korinek
type APC, point mutations were found in b-catenin et al., 1998). These observations suggest that Tcf4 may
which change any of the four serine/threonine residues be activated in the adult crypt by a localized Wnt signal
emanating from the surrounding mesenchymal cells.in its N terminus, the putative targets of GSK3 (Morin et
Cell
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observed in mice overexpressing N-terminally truncated
b-catenin (Harada et al., 1999).
Thus, the direct consequence of APC loss is an in-
crease in size of the proliferating crypt compartment.
This results in an abnormal tissue architecture which
presents as a polyp. Given that Tcf4 is normally required
for crypt maintenance (see above), it is conceivable that
inappropriate activation of Tcf4 by stabilized b-catenin
accounts for this apparent expansion of the crypt com-
partment. In other words, the polyp may be built from
cells that would normally migrate out of the crypt com-
partment to become differentiated, but that have been
misspecified by the activated Tcf4 to remain crypt cells.
Note that suppressive effects of activated b-catenin on
cellular differentiation have been observed (Harada et
al., 1999). All this is consistent with the notion that the
initial consequences of APC loss may reflect cell fate
changes due to the transcriptional activity of b-catenin/
Tcf4. Alternatively, these consequences could be due
to a defect in cell migration or adhesion of APC mutant
cells that are independent of nuclear b-catenin (see
below).
Why is the intestinal epithelium uniquely prone to can-
cer as a consequence of APC loss? This is essentially
not understood. Conceivably, the intestinal epithelium
may be unique in that misspecification by inappropri-
ately activated TCF in this tissue results in cells re-
maining in the stem cell compartment. It is also possible
that APC loss may confer growth arrest or even apopto-
sis in other tissues rather than net cell survival and
growth. Further explanations may include the possible
role of APC in migration and cellular adhesion, as out-
lined below. Finally, APC loss may be compensated for
Figure 2. Adenomatous Polyp Formation in Apc Mutant Mice by the second APC gene (Nakagawa et al., 1998; van
(A) Normal intestinal epithelium (yellow, crypt cells; blue, differenti- Es et al., 1999) in other tissues. Whatever the case, recall
ated cells in the villi). (B and C) Outpocketing pouches form at the that FAP patients who start life with one APC allele
proliferative zone of the crypt and protrude into the lacteal side of
already inactivated develop tumors in tissues other thanneighboring villi. (D–F) Microadenoma formation within single villi.
the colorectum. Interestingly, a recently developed sen-(G) Expansion of a microadenoma into a neighboring villus. (H) Multi-
villus polyp formed by fusion of multiple adenomas, in the process sitive detection method based on yeast has revealed
of rupturing through the villus epithelium to protrude into the gut inactivating APC mutations in a significant fraction of
lumen. Adenomatous tissue in pink. This figure is reproduced from primary breast cancers (Furuuchi et al., 2000). However,
Oshima et al. (1997). this finding awaits confirmation since it contrasts earlier
attempts to find such mutations. Note also that breast
cancer is neither prevalent in FAP patients, nor haveHowever, it is not known at present whether any of the
activating b-catenin mutants been found in this type ofWnts are expressed in this tissue at this stage.
cancer.Taketo and colleagues have studied the early effects
of APC loss in their heterozygous ApcD716 knockout mice
which develop intestinal adenomas at high frequency Progression to Malignancy
For the colorectal adenomas to progress to malignancy(Oshima et al., 1995, 1997). Polyp formation is initiated
by abnormal outpocketing of the intestinal epithelium and invasiveness, further genetic changes need to oc-
cur, as previously reviewed (Kinzler and Vogelstein,at the crypt–villus boundary (Figure 2B). The adenomal
pocket protrudes into the inside of the adjacent villus, 1996). One of the best documented ones is the apparent
loss of the response to TGF-b. TGF-b signaling canand subsequently grows to fill this space (Figure 2C-G)
while remaining covered by the villar epithelium. Even inhibit the growth rate of epithelial cells, and the re-
sponse to TGF-b is often lost in cancers (Polyak, 1996).after filling several adjacent villi and subsequent fusion,
much of the villar epithelium remains intact, and the In the mammalian intestinal epithelium, TGF-b ligands
and receptors are normally expressed in the villi (e.g.,polyp is barely exposed to the gut lumen (Figure 2H). It
is interesting that polyps are polyclonal, and that this Oshima et al., 1997), but it is not known whether these
signaling molecules function during the process of nor-polyclonality appears to be obligatory for tumor progres-
sion (Merritt et al., 1997). Note that all these events mal cell shedding in the intestine. TGF-b receptor type
II mutations are relatively common in replication error–precede the transition to malignancy. Importantly, there
is no increase in the rate of proliferation during the early prone colorectal tumor cell lines (Markowitz et al., 1995).
Furthermore, a small but significant fraction of colorectalstage of polyp formation. A similar sequence of events is
Review
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Figure 3. APC Proteins in Human and Dro-
sophila
Top, ubiquitous proteins (human APC, Dro-
sophila E-APC); bottom, proteins predomi-
nantly expressed in the nervous system
(human APC2, Drosophila dAPC). Gray, Arm-
adillo repeat domain; gray and black bars, 15
and 20 amino acid repeats, respectively, the
domains binding to b-catenin; red bars, Axin
binding motifs. Arrows point to functional
NESs in APC and E-APC (red; an N-terminal
NES conserved in APC2 is indicated by black
arrow). The MCR is marked by asterisk; re-
gions in APC that bind to Asef, microtubules
(MT) and EB1 are bracketed; the C-terminal
peptide T/SXV binds to human Dlg.
tumors show loss of the tumor suppressor DPC4, the tant colon cancer cells (Hayashi et al., 1997; Hamada
et al., 1999; van Es et al., 1999). They differ mainly bygene encoding human Smad4 which cotransduces all
their expression patterns: like APC, Drosophila E-APC/TGF-b-like signals, and some harbor mutations in the
dAPC2 is expressed ubiquitously (McCartney et al.,TGF-b transducing Smad2 (Moskaluk and Kern, 1996;
1999; Yu and Bienz, 1999), while dAPC and APC2/APCLRiggins et al., 1996). Finally, mice double-heterozygous
are primarily expressed in the nervous system (Hayashifor Apc and Smad4 mutations develop large intestinal
et al., 1997; Nakagawa et al., 1998; van Es et al., 1999).tumors that exhibit both hyperproliferation and invasive
The four genes share several conserved sequencebehavior (Takaku et al., 1998). These tumors all show
blocks (Figure 3). The most conserved of these is theloss of the second Apc and Smad4 alleles. This suggests
Armadillo repeat domain for which there is no well-docu-that, in the mouse intestinal tract, the loss of the re-
mented function as yet, although there is a recent reportsponse to TGF-b may suffice for the adenoma to pro-
that a G protein exchange factor, termed Asef, interactsgress to malignancy and invasiveness. Consistent with
with this domain (Kawasaki et al., 2000; see below). Eachthis, in humans, the earliest mutations in the TGF-b re-
APC protein also contains multiple b-catenin bindingceptor are found at the late adenoma stage, apparently
motifs (called 15 and 20 amino acid repeats; note thatcorrelating with the transition from benign adenoma to
the 15 amino acid repeats are missing in APC2/APCL)malignant carcinoma (Grady et al., 1998). However, there
and Axin/Conductin binding sites (“SAMP” repeats). Fi-is no experimental proof at present that the loss of TGF-b
nally, each except E-APC has a long C terminus, withresponsiveness brings about this transition.
scattered homology blocks throughout, which includesOncogenic activation of K-ras and mutations in p53
a region that in the human protein mediates binding toare also frequently observed in colorectal tumors, but
microtubules, to proteins of the EB/RP family and to theneither of these events alone appears to be sufficient
human homolog of the Drosophila tumor suppressorto initiate tumorigenesis (Kinzler and Vogelstein, 1996).
Discs large (Dlg). This C terminus is also present in theIn humans, oncogenic K-ras apparently contributes to
known mouse, rat, and Xenopus APC proteins each oftumor progression relatively early, namely during the
which is closely related to the human tumor suppressor.transition from moderate to late adenomas (Lamlum et
These and other proteins binding to APC have beenal., 2000). Surprisingly, activating ras mutations do not
discussed elsewhere (e.g., Polakis, 2000).seem to play a significant role in tumor progression in
Almost all APC mutations in colorectal tumors resultthe mouse. For example, no oncogenic K-ras mutations
in protein truncations, and the great majority of the mu-have been detected in adenomas and adenocarcinomas
tations in sporadic tumors are clustered in the centralof Apc mutant mice (Oshima et al., 1997; Smits et al.,
domain of APC, the mutation cluster region (MCR) (Na-1997; Takaku et al., 1998). On the other hand, deficiency
gase and Nakamura, 1993) (Figure 3). Typically, theseof p53 mildly enhances the multiplicity and invasiveness
truncations remove all binding sites for Axin/Conductin,
of intestinal adenomas in Apc mutant mice (Halberg et
and a strong case can be made that APC’s ability to
al., 2000). Thus, there appear to be some differences
bind to Axin is critical for its tumor suppressor function
between mice and humans in the factors that are impor- (Smits et al., 1999; von Kries et al., 2000). However,
tant for tumor progression. An explanation for this could additional functions may be encoded by sequences 39
be that APC loss and b-catenin activation lead to tumors to the MCR that contribute critically to this function.
predominantly in the small intestine of the mouse, but Nuclear b-catenin/Armadillo and TCF together bring
in the colorectum of humans. Furthermore, some of the about changes in gene transcription. This nuclear re-
apparent differences may reflect the different life and sponse is thought to be an early event in tumorigenesis
survival spans—on the order of months in mice, but (Korinek et al., 1997). Indeed, mutational inactivation of
decades in humans. Tcf1, a target gene of b-catenin/Tcf4 in mouse epithelial
cells, leads to adenomas in multiple tissues including
The Molecular Function of APC the gut (Roose et al., 1999). Tcf1 loss synergizes strongly
Humans and Drosophila both have two related APC with Apc heterozygosity in dramatically enhancing the
genes (Figure 3). Each of these is capable, like the tumor number and size of intestinal tumors. This apparent tu-
mor suppressor function of mouse Tcf1 was unex-suppressor, of reducing the b-catenin levels in APC mu-
Cell
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pected, given that TCFs typically promote Wnt pathway
activity (Figure 1). However, a plausible explanation for
this apparent paradox is that the most abundantly ex-
pressed epithelial isoform of Tcf1 is a dominant-nega-
tive TCF which lacks its b-catenin binding domain
(Roose et al., 1999).
Another TCF target gene that may contribute to tumor
progression in mice and humans encodes the metallo-
proteinase matrilysin (Brabletz et al., 1999; Crawford et
al., 1999). The functional significance of this finding is
supported by genetic evidence: the incidence and size
of intestinal tumors is markedly suppressed in Apc mu-
tant mice which also lack matrilysin function (Wilson et
al., 1997). Furthermore, the cell cycle promoting genes
c-myc and cyclin D1 have been identified as TCF target
genes (He et al., 1998; Tetsu and McCormick, 1999), as
well as PPARd, a putative target protein in colorectal
cancer for the beneficial effects of certain nonsteroidal
anti-inflammatory drugs (He et al., 1999). However, there
is no genetic evidence as yet to indicate the functional
relevance of these TCF target genes during normal de-
velopment or malignant transformation of the intestinal
Figure 4. Shuttling Model of APC Functionepithelium.
According to this model, APC shuttles b-catenin/Armadillo fromHow does APC destabilize b-catenin? This is poorly
the nucleus and the cytoplasm to the junctional compartment ofunderstood at the molecular level. As mentioned above,
epithelial cells. Here, b-catenin/Armadillo is delivered either to thethe Axin complex to which APC can bind earmarks
Axin complex to be earmarked for degradation, or to E-cadherin for
b-catenin for degradation by the proteasome pathway. incoporation into adherens junctions. Actin filaments could serve
However, overexpression of Axin in APC mutant colon as tracks to which APC may attach via a motor protein (black oval).
cancer cells is sufficient to reduce the high b-catenin Thus, APC may connect the two functional pools, junctional and
the free cytoplasmic, of b-catenin/Armadillo (see also Bienz, 1999).levels in these cells, thus bypassing the requirement for
APC in this process (Behrens et al., 1998; Hart et al.,
1998). This indicates a regulatory role of APC. A specific
b-catenin efficiently from the nucleus, or may even trapsuggestion has been that APC may somehow derepress
b-catenin in the nuclei of these cells. Whatever the case,Axin to facilitate its activity in the b-catenin-destabilizing
the nuclear export function of APC appears to be criticalcomplex (Hart et al., 1998). Alternatively, it has been
for its tumor suppressor function (Rosin-Arbesfeld etproposed that APC may have a spatial regulatory role,
al., 2000). Of note, b-catenin has been observed to beshuttling b-catenin around the cell (Bienz, 1999) (Figure
nuclear in colorectal tumors (Brabletz et al., 1998; Kolligs4). This model was inspired by the striking subcellular
et al., 2000).distribution of Drosophila E-APC which is associated
with apical adhesive junctions, but is also found in the
cytoplasm and in the nucleus (McCartney et al., 1999;
Functions of APC in Cell Migration and Adhesion?Yu et al., 1999). According to the shuttling model, APC
A corollary of the shuttling model is that APC loss maybinds to b-catenin/Armadillo in the cytoplasm and in the
not only affect transcription via nuclear b-catenin/Arma-nucleus and shuttles it to the junctional zones where it
dillo, but also cellular adhesion via the junctional pooldelivers it to the Axin complex for subsequent degrada-
of b-catenin/Armadillo. Indeed, it is beginning to emergetion, or to E-cadherin for incorporation into adhesive
that APC may have functions at the cell periphery thatjunctions. The model implies that APC connects the
are separate from its function effected by nucleartwo subcellular pools (free and junctional) of b-catenin/
b-catenin. Below, we shall discuss recent evidence fromArmadillo and maintains an equilibrium between them.
mammalian and Drosophila cells that suggest a role ofSupport for this model has recently come from the
APC in cellular migration and adhesion.discovery that APC contains nuclear export signals
An indication that APC may affect cell migration came(NES) which allow it to exit from the nucleus (Rosin-
from experiments in migratory mammalian tissue cultureArbesfeld et al., 2000; Henderson, 2000). Of particular
cells. In these cells, APC was found to cluster in mem-interest is the pair of NESs immediately downstream of
brane extensions at the plus ends of microtubulesthe MCR, conserved in all known APC proteins (Figure
(Na¨thke et al., 1996). Indeed, tagging of APC with green3), since these are deleted in almost all APC truncations
fluorescent protein allowed direct visualization of itsfound in sporadic colorectal tumors (Rosin-Arbesfeld et
ability to track along microtubules to peripheral cellularal., 2000). Consequently, truncated APC (only retaining
sites (Mimori-Kiyosue et al., 2000), illustrating the mobil-the N-terminal NES) is nuclear in cells derived from APC
ity of APC within cells (see Figure 4). Intriguingly, overex-mutant tumors. These cells also show high levels of
pression of N-terminal truncations of b-catenin that bindnuclear b-catenin, and these can only be reduced effi-
more stably to APC than wild-type b-catenin impairs theciently by exogenous APC which retain a minimum of
migratory properties of these cells (Barth et al., 1997).two NESs. It thus appears that the truncated APC typi-
cally observed in colon cancers may be unable to export Nelson and colleagues have argued that this is a conse-
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quence of the dynamics of APC–b-catenin interaction; the high nuclear b-catenin levels that result from this
it is conceivable that these APC “superbinders” may putative shift in equilibrium between the two b-catenin
exert dominant-negative effects on the shuttling of nor- pools which may be due to APC loss.
mal b-catenin by APC. Finally, it was discovered recently In summary, as initially suggested (e.g., Hu¨lsken et
that APC binds to Asef, an exchange factor that appar- al., 1994), APC could operate to suppress tumorigenesis
ently activates the small G protein Rac which in turn at the level of cell migration and adhesion. Both of these
controls the actin cytoskeleton (Kawasaki et al., 2000). processes might be affected by mutant forms of b-cat-
Evidence based on overexpression of exogenous pro- enin that interfere with the interaction between APC and
teins suggested that APC activates Asef at the mem- normal b-catenin (see above), but perhaps not by b-cat-
brane periphery and, as a consequence, induces cell enins with point mutations such as those found in can-
flattening and membrane ruffling, both signs of migra- cers. Thus, although the latter appear to be as potent
tory activity. This is perhaps the most persuasive evi- as APC loss regarding transcriptional activation (Morin
dence yet that APC may regulate cell migration. It seems et al., 1997), APC loss may have wider functional conse-
to do so by remodeling the actin cytoskeleton via Asef quences than oncogenic activation of b-catenin. Consis-
and Rac (Kawasaki et al., 2000). tent with this, oncogenic b-catenin mutations are rela-
Further suggestions that APC may affect directly cell tively common among small adenomas, but are very
shape and adhesion came from Drosophila. First, in the infrequent among invasive carcinomas, and oncogenic
developing eye, loss of the neuronal APC causes cell b-catenin is associated with less aggressive tumors than
shape changes that are mediated by Armadillo but not APC loss (Samowitz et al., 1999). Note also that g-cat-
by TCF (Ahmed et al., 1998). Second, depletion of E-APC enin has recently been found to be regulated, like
in the embryo produces subtle defects in the junctional b-catenin, by APC, and was shown to have oncogenic
association of Armadillo (Yu et al., 1999). Finally, a weak properties (Kolligs et al., 2000). All of this indicates that
mutation in E-APC that abolishes the association of the APC loss is more powerful than oncogenic activation of
mutant protein with junctional membranes causes par- b-catenin in promoting malignant development.
tial detachment of Armadillo from cadherin junctions as
well as a mild mutant phenotype in the ovary reminiscent Epilog
of the phenotype due to impaired cell adhesion in this The convergence of developmental biology and molecu-
tissue (Townsley and Bienz, 2000). Of note, the cellular lar oncology has outlined a crucial role for mutations
consequences of complete loss-of-function of APC in activating the Wnt pathway in causing colorectal tumors.
Drosophila are not known at present. Nevertheless, The pivotal event appears to be the formation of a consti-
these observations implicate Drosophila E-APC in the tutively active b-catenin/Tcf4 complex in the intestinal
maintenance of junctional integrity. It may be of interest epithelial cell. Additional functions of the APC tumor
in this context that human APC binds to the homolog suppressor in cell migration and adhesion may critically
of Drosophila Dlg (Matsumine et al., 1995), a septate contribute to the progression of tumors.
junction protein in Drosophila which is required for cell It will be of great interest to determine the complete
adhesion, and whose loss-of-function causes cell over-
spectrum of genes that are activated in response to
growth in this organism (Woods et al., 1996).
stabilized b-catenin during normal and malignant devel-
Further experimental support is needed to consoli-
opment of the intestine. The advent of DNA array tech-
date this putative role of APC in cellular migration and
nology will provide such insights. The b-catenin/Tcf4adhesion. Such a role could be relevant for APC’s func-
complex presents a well-defined target for therapeutiction as a tumor suppressor both at the early adenoma
intervention in cancer. However, it remains to be demon-stage as well as at late stages of tumor progression. As
strated whether the disruption of this complex by smallmentioned above, one of the earliest manifestations of
molecular compounds in an adenoma, let alone in aAPC loss in the intestinal epithelium is an abnormal
carcinoma with multiple additional mutations, will havetissue architecture which may reflect a defect in cell
beneficial effects by reversing the course of carcino-migration or adhesion. Furthermore, it is well established
genesis.that cadherin-mediated adhesion is typically lost at the
invasive front of tumors where cells become migratory,
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